These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16482517)

  • 1. Expression of heregulin by mouse mammary tumor cells: role in activation of ErbB receptors.
    Schmitt M; Walker MP; Richards RG; Bocchinfuso WP; Fukuda T; Medina D; Kittrell FS; Korach KS; DiAugustine RP
    Mol Carcinog; 2006 Jul; 45(7):490-505. PubMed ID: 16482517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas.
    Balañá ME; Lupu R; Labriola L; Charreau EH; Elizalde PV
    Oncogene; 1999 Nov; 18(46):6370-9. PubMed ID: 10597237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells.
    Ram TG; Hosick HL; Ethier SP
    J Cell Physiol; 2000 Jun; 183(3):301-13. PubMed ID: 10797304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
    Ethier SP; Kokeny KE; Ridings JW; Dilts CA
    Cancer Res; 1996 Feb; 56(4):899-907. PubMed ID: 8631031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The extracellular region of heregulin is sufficient to promote mammary gland proliferation and tumorigenesis but not apoptosis.
    Weinstein EJ; Leder P
    Cancer Res; 2000 Jul; 60(14):3856-61. PubMed ID: 10919660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-I in human mammary epithelial cells.
    Ram TG; Kokeny KE; Dilts CA; Ethier SP
    J Cell Physiol; 1995 Jun; 163(3):589-96. PubMed ID: 7775601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression.
    Xu F; Yu Y; Le XF; Boyer C; Mills GB; Bast RC
    Clin Cancer Res; 1999 Nov; 5(11):3653-60. PubMed ID: 10589783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking HER-2/HER-3 function with a dominant negative form of HER-3 in cells stimulated by heregulin and in breast cancer cells with HER-2 gene amplification.
    Ram TG; Schelling ME; Hosick HL
    Cell Growth Differ; 2000 Mar; 11(3):173-83. PubMed ID: 10768865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
    Ethier SP; Langton BC; Dilts CA
    Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo.
    Atlas E; Cardillo M; Mehmi I; Zahedkargaran H; Tang C; Lupu R
    Mol Cancer Res; 2003 Jan; 1(3):165-75. PubMed ID: 12556556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction or suppression of expression of cytochrome C oxidase subunit II by heregulin beta 1 in human mammary epithelial cells is dependent on the levels of ErbB2 expression.
    Sun Y; Lin H; Zhu Y; Ma C; Ye J; Luo J
    J Cell Physiol; 2002 Aug; 192(2):225-33. PubMed ID: 12115729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175.
    Schaefer G; Fitzpatrick VD; Sliwkowski MX
    Oncogene; 1997 Sep; 15(12):1385-94. PubMed ID: 9333014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heregulin-triggered Her-2/neu signaling enhances nuclear accumulation of p21WAF1/CIP1 and protects breast cancer cells from cisplatin-induced genotoxic damage.
    Menendez JA; Mehmi I; Lupu R
    Int J Oncol; 2005 Mar; 26(3):649-59. PubMed ID: 15703820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive activation of the neuregulin-1/ErbB receptor signaling pathway is essential for the proliferation of a neoplastic Schwann cell line.
    Frohnert PW; Stonecypher MS; Carroll SL
    Glia; 2003 Aug; 43(2):104-18. PubMed ID: 12838503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer.
    Tsai MS; Shamon-Taylor LA; Mehmi I; Tang CK; Lupu R
    Oncogene; 2003 Feb; 22(5):761-8. PubMed ID: 12569369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH; Lin CC; Lin JK; Chen WJ
    J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Src family kinases and HER2 interactions in human breast cancer cell growth and survival.
    Belsches-Jablonski AP; Biscardi JS; Peavy DR; Tice DA; Romney DA; Parsons SJ
    Oncogene; 2001 Mar; 20(12):1465-75. PubMed ID: 11313890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heregulin-dependent autocrine loop regulates growth of K-ras but not erbB-2 transformed rat thyroid epithelial cells.
    Mincione G; Piccirelli A; Lazzereschi D; Salomon DS; Colletta G
    J Cell Physiol; 1998 Aug; 176(2):383-91. PubMed ID: 9648926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivo.
    Yang D; Kuan CT; Payne J; Kihara A; Murray A; Wang LM; Alimandi M; Pierce JH; Pastan I; Lippman ME
    Clin Cancer Res; 1998 Apr; 4(4):993-1004. PubMed ID: 9563895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.